Continuous glucose monitoring for gestational diabetes
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests whether using a continuous glucose monitor (a small sensor that checks your blood sugar all day) can improve outcomes for you and your baby during gestational diabetes. It may help you manage your blood sugar more easily and reduce risks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have been diagnosed with gestational diabetes (diabetes that started during your pregnancy).
- You did not have diabetes before you became pregnant.
- Your skin is not allergic to medical tape or patches (no redness, itching, swelling, or blisters from them).
- You do not have a bleeding or clotting problem.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help women who had gestational diabetes reduce their future risk of heart disease and diabetes. It checks if monitoring and support can improve health after pregnancy.
This trial tests whether a continuous glucose monitor can help women with type 2 diabetes who are pregnant and need insulin therapy. It aims to improve blood sugar control and pregnancy outcomes.
This study compares using a continuous glucose monitor (a small sensor that tracks sugar levels all day) with the usual finger-prick testing in women with gestational diabetes. The goal is to see if the monitor helps control blood sugar better and is easier to use.
This study tests a continuous glucose monitor (a small patch that tracks your blood sugar) for a few weeks after you give birth. It aims to see if this tool can help women who recently had gestational diabetes better understand their blood sugar levels after delivery.
This study compares a continuous glucose monitor (CGM) to standard finger-prick testing for managing gestational diabetes. It aims to see if the CGM can improve blood sugar control and maternal outcomes.
This study uses a continuous glucose monitor (a small sensor that tracks your blood sugar) after you give birth to see if your blood sugar levels return to normal. It may help detect early signs of type 2 diabetes and guide your postpartum care.
Hear when a new Continuous Glucose Monitoring trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.